[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366850-105":59,"doc-detail-366850-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeted-therapy-with-rhenium-aided-therapy-for-cutaneous-lesions-a-systematic-review-and-meta-analysis","Targeted β-therapy with rhenium-aided therapy for cutaneous lesions - a systematic review and meta-analysis","","Non-melanoma skin cancer is a highly prevalent malignancy, and standard primary treatments can sometimes produce incomplete results and raise recurrence risk. This systematic review and meta-analysis evaluates studies published up to July 2025 assessing rhenium-assisted therapies for cutaneous lesions, focusing on therapeutic efficacy and potential adverse effects. The review analyzes response rates, including complete and overall responses, and applies leave-one-out sensitivity analysis to examine heterogeneity and robustness of pooled effects.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeted-therapy-with-rhenium-aided-therapy-for-cutaneous-lesions-a-systematic-review-and-meta-analysis/366850/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeted-therapy-with-rhenium-aided-therapy-for-cutaneous-lesions-a-systematic-review-and-meta-analysis/366850.png","ImageObject",300,407,{"name":92,"@type":93},"OmBimo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does this systematic review address?","Question",{"text":112,"@type":113},"It assesses therapeutic efficacy and potential adverse effects of rhenium-assisted therapies for cutaneous lesions, using response rate as the primary endpoint.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What outcomes were reported in the meta-analysis?",{"text":117,"@type":113},"Rhenium-assisted therapy showed an 88.67% complete response rate and a 92.9% overall response rate in the pooled analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"How was heterogeneity evaluated?",{"text":121,"@type":113},"A leave-one-out analysis was performed to determine each study’s impact on heterogeneity, identifying an outlier that substantially influenced the pooled effect.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366850,1790410876,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","OPEN ACCESS  \nEDITED BY  \nLuca Urso,  \nUniversity of Ferrara, Italy  \nREVIEWED BY  \nMohsen Farsad,  \nBolzano Central Hospital, Italy Luigia Vetrone,  \nIRCCS University Hospital of Bologna Sant Orsola Polyclinic, Italy  \n*CORRESPONDENCE  \nAlessio Rizzo  \n [alessio.rizzo@ircc.it](alessio.rizzo@ircc.it)  \nRECEIVED 17 September 2025  \nREVISED 03 November 2025  \nACCEPTED 10 November 2025  \nPUBLISHED 27 November 2025  \nCITATION  \nSadeghpour S, Sadeghi R, Aghaee A, Saber Tanha A, Rizzo A, Treglia G and  \nSadeghpour S (2025) Targeted β-therapy with rhenium-aided therapy for cutaneous lesions: a systematic review and meta-analysis.  \nFront. Med. 12:1707729.  \ndoi: 10.3389/fmed.2025.1707729  \nCOPYRIGHT  \n© 2025 Sadeghpour, Sadeghi, Aghaee, Saber Tanha, Rizzo, Treglia and Sadeghpour. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nTYPE Systematic Review PUBLISHED 27 November 2025 DOI 10.3389/fmed.2025.1707729  \nTargeted β-therapy with rhenium-aided therapy for cutaneous lesions: a systematic review and meta-analysis  \nSajjad Sadeghpour 1, Ramin Sadeghi 1, Atena Aghaee 1, Amin Saber Tanha 1, Alessio Rizzo 2*, Giorgio Treglia3,4,5 and Saba Sadeghpour 6  \n1Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran, 2Nuclear Medicine Unit, Candiolo Cancer Institute, FPO–IRCCS, Turin, Italy, 3Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland, 4Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland, 5Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland, 6Madani Hospital, Gonabad University of Medical Sciences, Gonabad, Iran  \nBackground: Non-melanoma skin cancer is the most prevalent malignancy. Primary treatments may at times yield suboptimal results. In these cases, alternative therapies or the combination of different modalities may be required to achieve complete removal and prevent the risk of recurrence.  \nMethods: We examined studies published up to July 2025 using databases such as PubMed and Scopus, focusing on the performance of rhenium-assisted therapies with respect to therapeutic efficacy and potential adverse effects. Studies investigating the therapeutic outcomes of rhenium-assisted therapies for cutaneous lesions were considered. The primary endpoint was the response rate to rhenium-assisted therapies.  \nResults: This systematic review and meta-analysis included 10 studies involving 433 patients and more than 618 lesions. Of these, seven studies were included in the meta-analysis, in which rhenium-assisted therapy achieved a complete response rate of 88.67%(95% CI: 84.7–91.7%) and an overall response rate of 92.9%(95% CI: 89.1–95. 5%) . A leave-one-out analysis was performed to assess the study’s impact on heterogeneity, revealing that one study markedly influenced the pooled effect. By excluding this outlier, heterogeneity was substantially reduced, while the overall mean effect remained significant (complete response 94, 95% CI [90, 96%]; overall response 97, 95% CI [92, 99%]) . Conclusion: Rhenium-assisted therapy for skin cancer appears effective and safe in treating lesions unresponsive to standard options. It may represent a valuable tool, providing advantages over conventional approaches. Further studies are warranted to confirm its efficacy and establish standardized protocols.  \nKEYWORDS  \nskin cancer, rhenium, resin, skin cancer therapy, systematic review, cutaneous lesion, non-melanoma skin cancer  \nFrontiers in Medicine 01 [frontiersin.org](frontiersin.org)  \n1 Introductio","cbCaisEBh4jCbi0Z","https://ap.wps.com/l/cbCaisEBh4jCbi0Z","pdf",1709662,12,"English","# Background\n# Methods\n# Results\n## Meta-analysis outcomes\n## Leave-one-out sensitivity\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What question does this systematic review address?\",\"answer\":\"It assesses therapeutic efficacy and potential adverse effects of rhenium-assisted therapies for cutaneous lesions, using response rate as the primary endpoint.\"},{\"question\":\"What outcomes were reported in the meta-analysis?\",\"answer\":\"Rhenium-assisted therapy showed an 88.67% complete response rate and a 92.9% overall response rate in the pooled analysis.\"},{\"question\":\"How was heterogeneity evaluated?\",\"answer\":\"A leave-one-out analysis was performed to determine each study’s impact on heterogeneity, identifying an outlier that substantially influenced the pooled effect.\"}]","Targeted β-therapy with rhenium-aided therapy for cutaneous lesions - a systematic review and meta-analysis | PDF",1790167935,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad2a68e267905baa30f31a1b6ec685e7.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01d7c593a730ee3a3fd429a37cb8e10a.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1083fee7036d75e2ba61c988b780bf2a.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5174818b5eea6ab4ff80ce9641d3ce2e.webp",980,1385]